
doi: 10.4155/fmc.12.48
pmid: 22571611
Chemokines and their receptors have a multifaceted role in tumor biology and are implicated in nearly all aspects of cancer growth, survival and dissemination. Modulation of the interaction between chemokines and their cell surface receptor is, therefore, a promising area for the development of new cancer medicines. In this review, we look at the compelling evidence that is emerging to support targeting CXC chemokines, also known as family α chemokines, as novel therapeutic strategies in the treatment of cancer.
Receptors, CXCR, Antineoplastic Agents, Gene Expression Regulation, Neoplastic, Small Molecule Libraries, Neoplasms, Drug Discovery, Animals, Humans, Molecular Targeted Therapy, Chemokines, CXC
Receptors, CXCR, Antineoplastic Agents, Gene Expression Regulation, Neoplastic, Small Molecule Libraries, Neoplasms, Drug Discovery, Animals, Humans, Molecular Targeted Therapy, Chemokines, CXC
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 31 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
